Reaction
Cd19 Lymphocytes Decreased reporting signals
As of the last recalculation, Cd19 Lymphocytes Decreased appears in 128 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is OCRELIZUMAB (PRR 314.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ocrelizumab | 62 | 314.4 | 314.7 |
| Ofatumumab | 20 | 115.8 | 115.9 |
| Blinatumomab | 5 | 81.1 | 81.1 |